ACVC Premium Access

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Event: Acute Cardiovascular Care 2019
Topic: Antiplatelet Drugs
Session type: Special Session
Date: 2 March 2019
Time: 14:00 - 15:30

Congress Session

5 presentations in this session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Introduction.

Speaker: Professor P. Vranckx (Hasselt, BE)
Thumbnail

Design, statistics, and pitfalls of a pragmatic clinical trial.

Speaker: Professor K. Rowan (London, GB)
Thumbnail

What are the implications of GLOBAL LEADERS for clinical practice?

Speaker: Professor K. Huber (Vienna, AT)
Thumbnail

Compliment the Investigators Assessment: the GLOBAL LEADERS Adjudication SubSTudy.

Speaker: Doctor A. Franzone (Naples, IT)
Thumbnail

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Conclusion.

Speaker: Professor M. Valgimigli (Lugano, CH)
Thumbnail

5 speakers from this session

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)
22 presentations
0 follower

Professor Kathy Rowan

Intensive Care National Audit And Research Centre, London (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

Doctor Anna Franzone

Federico II University Hospital, Naples (Italy)
5 presentations
0 follower

Professor Marco Valgimigli

Cardiocentro Ticino Foundation, Lugano (Switzerland)
22 presentations
1 follower

This platform is supported by

logo Novo Nordisk